The pioneer company in China’s premium electric vehicle market reported quarterly figures that came ahead of consensus
Nio, the Chinese start-up, posted a revenue surge of 127.2% year-on-year to hit 8.45 billion yuan, surpassing the 8.32 billion yuan forecasted. The carmaker revealed it delivered 21,896 vehicles in Q2, within its previously-stated range. On the other hand, the company reported a loss per share of 0.42 yuan, less than the 0.68-yuan loss previously touted. The figures came in narrower than the 1.15-yuan loss per share reported in the same period last year.
For the third quarter, Nio expects its revenue to reach a high of 9.63 billion yuan, a 112.8% rise from the same quarter of 2020. Also, the company forecasts that it will deliver between 23,000 and 25,000 vehicles. Next year, Nio also gears up to deliver its first sedan – ET7, along with two other new products.
William Bin Li, Nio CEO, stated: “As the EV adoption begins to reach a tipping point worldwide, we believe it is imperative to speed up the launch of new products to provide more premium smart EV offerings with superior holistic services to the growing user base in the global market.”
Despite the promising outlook, Nio and other electric carmakers are facing headwinds because of the ongoing global chip shortage, which could affect production. The resurgence of COVID-19 cases in China could potentially harm sales.
After the report, Nio stock price rose more than 1%.
Sources: cnbc.com, reuters.com
Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.
Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance and forecasts are not reliable indicators of future results.